Eupraxia Pharmaceuticals Financial Overview
Eupraxia Pharmaceuticals's market cap is currently C$496.75M. The company's EPS TTM is C$-0.268; its P/E ratio is -8.23; Eupraxia Pharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is C$-0.19. See an overview of income statement, balance sheet, and cash flow financials.
